This hypothesis is further supported by observations of gastrointestinal stromal tumor (GIST) patients treated with imatinib, a c-Kit inhibitor, 42 % of whom exhibited macrocytosis [20]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.